Cargando…
Is there evidence of anti-malarial multidrug resistance in Burkina Faso?
Recently, Gansané and colleagues published an article on inadequate efficacy of two different forms of artemisinin-based combination therapy (ACT) in Burkina Faso. The development of Plasmodium falciparum resistance to different ACT partner drugs at levels that could affect the efficacy of two ACT w...
Autores principales: | Rasmussen, Charlotte, Ringwald, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287766/ https://www.ncbi.nlm.nih.gov/pubmed/34281562 http://dx.doi.org/10.1186/s12936-021-03845-5 |
Ejemplares similares
-
Substandard anti-malarial drugs in Burkina Faso
por: Tipke, Maike, et al.
Publicado: (2008) -
The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
por: Guissou, Rosemonde M., et al.
Publicado: (2023) -
Contamination of street food with multidrug-resistant Salmonella, in Ouagadougou, Burkina Faso
por: Nikiema, Marguerite E. M., et al.
Publicado: (2021) -
Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
por: Gansané, Adama, et al.
Publicado: (2021) -
Multidrug-Resistant Tuberculosis in Burkina Faso from 2006 to 2017: Results of National Surveys
por: Diandé, Souba, et al.
Publicado: (2019)